4 results
Approved WMORecruiting
To assess the efficacy of AZD9291 compared to placebo as measured by disease free survival (DFS)Protocol v1.0, 4Jun2015, p30
Approved WMORecruiting
To investigate the effect of a CYP3A4 inducer (rifampicin) on the PK of AZD9291.
Approved WMORecruiting
To investigate the effect of a CYP3A4 inhibitor (itraconazole) on the PK of AZD9291.
Approved WMORecruiting
To assess to efficacy of locally applied tacrolimus suppositories compared to beclomethason suppositories in patients with recurrent or refactory ulcerative proctitis.